Prevalence and clinical characteristics of migraine in France

被引:194
作者
Henry, P
Auray, JP
Gaudin, AF
Dartigues, JF
Duru, G
Lantéri-Minet, M
Lucas, C
Pradalier, A
Chazot, G
El Hasnaoui, A
机构
[1] Hop Pellegrin Tripode, Serv Neurol, F-33076 Bordeaux, France
[2] Univ Lyon 1, F-69365 Lyon, France
[3] Lab GlaxoSmithKline, Marly Le Roi, France
[4] Univ Bordeaux 2, Nice, France
[5] Hop Louis Pasteur, F-06002 Nice, France
[6] Hop Roger Salengro, Lille, France
[7] Hop Louis Mourier, F-92701 Colombes, France
[8] Hop Neurol, Lyon, France
关键词
D O I
10.1212/WNL.59.2.232
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine the prevalence and clinical features of migraine and related headache types in France. Methods: The authors recruited a population of subjects with headache representative of the national population using a stratified sampling method. They screened 10,585 subjects aged 15 and older who were representative of the general population. They identified 1,486 of these as having headaches, and these subjects were subsequently interviewed for information on clinical features, natural history, and functional impact of headache. The authors categorized subjects based on the International Headache Society (IHS) classification and assessed disability using the MIDAS questionnaire. Results: The authors found a standardized prevalence for migraine (IHS categories 1.1 and 1.2) of 7.9% (11.2% for women and 4.0% for men) and 9.1% for migrainous disorder (IHS category 1.7). Migraine attacks were associated with a considerable degree of handicap in activities of daily living, with a MIDAS grade distribution of 74.7% (grade 1), 13.3% (grade 2), 7.7% (grade 3), and 4.3% (grade 4). The prevalence of migraine with MIDAS grade 3 or 4 was 1.6%. Conclusions: The prevalence of migraine (IHS categories 1.1 and 1.2) in France is 7.9%, and that of total migraine is 17.0%; this does not seem to have evolved over the past 10 years.
引用
收藏
页码:232 / 237
页数:6
相关论文
共 22 条
[1]   The impact of migraine - Epidemiology, risk factors, and co-morbidities [J].
Breslau, N ;
Rasmussen, BK .
NEUROLOGY, 2001, 56 (06) :S4-S12
[2]   Epidemiology of chronic daily headache in the general population [J].
Castillo, J ;
Muñoz, P ;
Guitera, V ;
Pascual, J .
HEADACHE, 1999, 39 (03) :190-196
[3]   THE EPIDEMIOLOGY OF HEADACHE IN GERMANY - A NATIONWIDE SURVEY OF A REPRESENTATIVE SAMPLE ON THE BASIS OF THE HEADACHE CLASSIFICATION OF THE INTERNATIONAL-HEADACHE-SOCIETY [J].
GOBEL, H ;
PETERSENBRAUN, M ;
SOYKA, D .
CEPHALALGIA, 1994, 14 (02) :97-106
[4]   A NATIONWIDE SURVEY OF MIGRAINE IN FRANCE - PREVALENCE AND CLINICAL-FEATURES IN ADULTS [J].
HENRY, P ;
MICHEL, P ;
BROCHET, B ;
DARTIGUES, JF ;
TISON, S ;
SALAMON, R .
CEPHALALGIA, 1992, 12 (04) :229-237
[5]   The prevalence and characteristics of migraine in a population-based cohort - The GEM Study [J].
Launer, LJ ;
Terwindt, GM ;
Ferrari, MD .
NEUROLOGY, 1999, 53 (03) :537-542
[6]  
Lipton RB, 1998, CLIN NEUROSCI, V5, P2
[7]   AN UPDATE ON THE EPIDEMIOLOGY OF MIGRAINE [J].
LIPTON, RB ;
SILBERSTEIN, SD ;
STEWART, WF .
HEADACHE, 1994, 34 (06) :319-328
[8]   Prevalence and burden of migraine in the United States: Data from the American Migraine Study II [J].
Lipton, RB ;
Stewart, WF ;
Diamond, S ;
Diamond, ML ;
Reed, M .
HEADACHE, 2001, 41 (07) :646-657
[9]   The role of headache-related disability in migraine management - Implications for headache treatment guidelines [J].
Lipton, RB ;
Silberstein, SD .
NEUROLOGY, 2001, 56 (06) :S35-S42
[10]  
LIPTON RB, 2000, JAMA-J AM MED ASSOC, V284, P2640